Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.
Division of Psychiatry, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
Psychiatry Clin Neurosci. 2019 Apr;73(4):187-193. doi: 10.1111/pcn.12812. Epub 2019 Feb 8.
Fibromyalgia is often comorbid with depression, and less than half those patients achieve satisfactory improvement after adequate pharmacological intervention. The investigation of repetitive transcranial magnetic stimulation (rTMS) at left dorsolateral prefrontal cortex for modified-2010 American College of Rheumatology (ACR) fibromyalgia and major depressive disorder (MDD) is still in its infancy.
In this double-blind, randomized, sham-control study, subjects diagnosed with ACR-2010 fibromyalgia and DSM-IV-TR MDD were recruited and received either active or sham interventions for 2 weeks. Hamilton Depression Rating Scale (HDRS) and the 10-cm visual analogue pain scale were evaluated at baseline, week 1, and week 2. Multivariable generalized estimating equations analysis was performed for the association between depression and pain scores at each checkpoint.
Twenty subjects were recruited. There was a significant difference over the 2 weeks between the rTMS and sham stimulation groups (P = 0.029), but subgroup analyses were further performed due to significant interaction of group and HDRS on pain outcomes (P = 0.020). The active group had significant improvement in pain at week 2 compared with week 1 (P = 0.021), but the control group did not have any improvement in pain (P = 0.585). Of the mild-moderate depression patients, the pain score in the active group was significantly lower than in the sham group at week 1 (P = 0.001) and at week 2 (P < 0.001). For the severe depression group, there was significantly lower pain over the 2 weeks in the active group (P = 0.045) but the sham group had significantly relapsing pain at week 2 (P < 0.001).
Left prefrontal rTMS has an analgesic effect in modified-ACR 2010-defined fibromyalgia and MDD patients. Further investigation is required, however, in order to determine how to regulate the different rTMS treatment protocols according to individual baseline depression severity in patients with MDD and fibromyalgia.
纤维肌痛常与抑郁症共病,不足半数患者在充分药物干预后获得满意改善。左背外侧前额叶皮层重复经颅磁刺激(rTMS)治疗改良美国风湿病学会(ACR)2010 年纤维肌痛和重度抑郁症(MDD)的研究仍处于初级阶段。
本双盲、随机、假刺激对照研究纳入诊断为 ACR-2010 纤维肌痛和 DSM-IV-TR MDD 的患者,分别接受真刺激或假刺激治疗 2 周。基线时、第 1 周和第 2 周时评估汉密尔顿抑郁量表(HDRS)和 10cm 视觉模拟疼痛量表。多变量广义估计方程分析用于评估各时间点抑郁和疼痛评分之间的相关性。
共纳入 20 例患者。rTMS 组和假刺激组在 2 周内存在显著差异(P=0.029),但由于组和 HDRS 对疼痛结果的交互作用显著(P=0.020),进一步进行了亚组分析。与第 1 周相比,真刺激组第 2 周疼痛显著改善(P=0.021),但假刺激组疼痛无任何改善(P=0.585)。在轻度至中度抑郁患者中,真刺激组第 1 周和第 2 周的疼痛评分均显著低于假刺激组(P=0.001 和 P<0.001)。对于重度抑郁组,真刺激组在 2 周内疼痛明显减轻(P=0.045),但假刺激组在第 2 周疼痛明显加重(P<0.001)。
左前额叶 rTMS 对改良 ACR 2010 定义的纤维肌痛和 MDD 患者具有镇痛作用。然而,需要进一步研究,以确定如何根据 MDD 和纤维肌痛患者的基线抑郁严重程度调节不同的 rTMS 治疗方案。